You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH)不再持有佛山禪曦股權
格隆匯 05-31 19:00

格隆匯5月31日丨復星醫藥(600196.SH)公佈,為聚焦主業,2021年4月26日,控股子公司禪城醫院、上海復星醫療(集團)有限公司(現已更名為上海復星健康科技(集團)有限公司)、佛山禪曦與關聯方豫園股份(600655.SH)共同簽訂《股權和債權轉讓合同》,出讓方(即禪城醫院及復星醫療)擬向受讓方(即豫園股份或其指定控股子公司)轉讓所持有的佛山禪曦合計100%股權以及截至2020年12月31日分別對佛山禪曦享有的股東債權。該次轉讓總價為人民幣5.50億元,其中:股權轉讓價款共計約人民幣1.76億元、債權轉讓價款共計約人民幣3.74億元。

根據約定,佛山禪曦與禪城醫院將繼續履行2020年1月簽訂的《定製協議》(簡稱“後續交易”),由佛山禪曦為禪城醫院定製建設用於運營婦女兒童醫學中心、養護院的相關物業(即“禪醫健康城綜合體項目”中的第5座住院樓和第6座養護院,合稱“定製工程”),於該等定製工程完成竣工驗收備案後及時交付禪城醫院使用,並以資產轉讓的方式將定製工程的產權辦理至禪城醫院名下。

該次交易(包括該次轉讓及後續交易)已經公司第八屆董事會第三十九次會議及2021年第一次臨時股東大會審議通過。該次轉讓已於2021年5月31日完成工商變更登記,集團不再持有佛山禪曦的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account